Ole Vorm
Fondatore presso Evosep ApS
Profilo
Ole Vorm is the founder of Proxeon Biosystems ApS, Evosep ApS, and OmicEra Diagnostics GmbH, which were founded in 2002, 2016, and 2019 respectively.
At Proxeon Biosystems ApS, he held the title of Director & Chief Scientific Officer.
At Evosep ApS, he currently holds the title of Chairman.
At OmicEra Diagnostics GmbH, he currently holds the title of Chief Executive Officer.
Dr. Vorm's current job is as a Director at Fida Biosystems ApS.
He previously worked as a Principal at MDS Proteomics, Inc. Dr. Vorm received his graduate and doctorate degrees from the University of Southern Denmark.
Posizioni attive di Ole Vorm
| Società | Posizione | Inizio |
|---|---|---|
Evosep ApS
 Evosep ApS Miscellaneous Commercial ServicesCommercial Services Evosep ApS provides commercial physical research services. It develops and markets laboratory equipment. The company was founded on March 1, 2016 and is headquartered in Odense, Denmark. | Fondatore | 01/04/2016 |
Fida Biosystems ApS
 Fida Biosystems ApS Packaged SoftwareTechnology Services Fida Biosystems ApS offers research and development of point-of-care technologies. Its technology enables to carry out analyses of information on complex binding interactions and concentration of proteins, particles, antibodies, and other biomolecules. The company is headquartered in Copenhagen, Denmark. | Direttore/Membro del Consiglio | - |
OmicEra Diagnostics GmbH
 OmicEra Diagnostics GmbH Packaged SoftwareTechnology Services Part of EXACT Sciences Corp., OmicEra Diagnostics GmbH is a German company that aims to revolutionize patient care by implementing mass spectrometry-based proteomics in routine medical diagnostics. The company is based in Planegg, Germany. OmicEra employs innovative technology, automated workflows, and AI to maximize knowledge gain. The company was founded by Philipp E. Geyer, Sophia Doll, Sebastian Virreira Winter, Ole Vorm. Ole Vorm has been the CEO since incorporation. OmicEra Diagnostics was acquired by EXACT Sciences Corp. on May 02, 2022 for $16.53 million. | Amministratore Delegato | 01/01/2019 |
Precedenti posizioni note di Ole Vorm
| Società | Posizione | Fine |
|---|---|---|
| MDS Proteomics, Inc. | Corporate Officer/Principal | - |
Proxeon Biosystems ApS
 Proxeon Biosystems ApS BiotechnologyHealth Technology Proxeon Biosystems ApS develops and sells technology, equipment, and supplies for biotechnology and clinical research. The company was founded by Ole Vorm on October 31, 2002 and is headquartered in Roskilde, Denmark. | Fondatore | - |
Formazione di Ole Vorm
| University of Southern Denmark | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
| MDS Proteomics, Inc. | Commercial Services |
Proxeon Biosystems ApS
Proxeon Biosystems ApS BiotechnologyHealth Technology Proxeon Biosystems ApS develops and sells technology, equipment, and supplies for biotechnology and clinical research. The company was founded by Ole Vorm on October 31, 2002 and is headquartered in Roskilde, Denmark. | Health Technology |
Evosep ApS
Evosep ApS Miscellaneous Commercial ServicesCommercial Services Evosep ApS provides commercial physical research services. It develops and markets laboratory equipment. The company was founded on March 1, 2016 and is headquartered in Odense, Denmark. | Commercial Services |
Fida Biosystems ApS
Fida Biosystems ApS Packaged SoftwareTechnology Services Fida Biosystems ApS offers research and development of point-of-care technologies. Its technology enables to carry out analyses of information on complex binding interactions and concentration of proteins, particles, antibodies, and other biomolecules. The company is headquartered in Copenhagen, Denmark. | Technology Services |
OmicEra Diagnostics GmbH
OmicEra Diagnostics GmbH Packaged SoftwareTechnology Services Part of EXACT Sciences Corp., OmicEra Diagnostics GmbH is a German company that aims to revolutionize patient care by implementing mass spectrometry-based proteomics in routine medical diagnostics. The company is based in Planegg, Germany. OmicEra employs innovative technology, automated workflows, and AI to maximize knowledge gain. The company was founded by Philipp E. Geyer, Sophia Doll, Sebastian Virreira Winter, Ole Vorm. Ole Vorm has been the CEO since incorporation. OmicEra Diagnostics was acquired by EXACT Sciences Corp. on May 02, 2022 for $16.53 million. | Technology Services |
- Borsa valori
- Insiders
- Ole Vorm
